Atwood & Palmer Inc. boosted its stake in shares of Cerner Co. (NASDAQ:CERN) by 4.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,744 shares of the company’s stock after buying an additional 771 shares during the period. Atwood & Palmer Inc.’s holdings in Cerner were worth $1,188,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Janus Capital Management raised its position in Cerner by 51.5% in the third quarter. Janus Capital Management now owns 1,830,393 shares of the company’s stock valued at $109,750,000 after buying an additional 622,500 shares in the last quarter. LGT Capital Partners bought a new stake in Cerner during the fourth quarter worth $963,000. Capital Investment Services of America increased its stake in Cerner by 1.2% in the fourth quarter. Capital Investment Services of America now owns 185,182 shares of the company’s stock worth $11,142,000 after buying an additional 2,250 shares during the last quarter. Creative Planning increased its stake in Cerner by 40.8% in the fourth quarter. Creative Planning now owns 302,581 shares of the company’s stock worth $18,206,000 after buying an additional 87,647 shares during the last quarter. Finally, Crestpoint Capital Management increased its stake in Cerner by 1.2% in the fourth quarter. Crestpoint Capital Management now owns 8,700 shares of the company’s stock worth $523,000 after buying an additional 100 shares during the last quarter.

Shares of Cerner Co. (NASDAQ:CERN) opened at 58.01 on Monday. Cerner Co. has a 1-year low of $53.91 and a 1-year high of $75.72. The company has a market cap of $19.85 billion and a price-to-earnings ratio of 39.20. The stock has a 50 day moving average of $58.62 and a 200 day moving average of $62.27.

Cerner (NASDAQ:CERN) last posted its quarterly earnings data on Tuesday, November 3rd. The company reported $0.54 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.54. The company earned $1.13 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter last year, the company posted $0.42 earnings per share. The firm’s revenue for the quarter was up 34.1% on a year-over-year basis. Analysts predict that Cerner Co. will post $2.07 EPS for the current year.

A number of equities research analysts have recently weighed in on the stock. Cowen and Company raised their price target on shares of Cerner from $75.00 to $76.00 and gave the company an “outperform” rating in a research note on Monday, November 2nd. Leerink Swann raised their price target on shares of Cerner from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Monday, November 2nd. KeyBanc raised their price target on shares of Cerner from $70.00 to $77.00 and gave the company a “buy” rating in a research note on Monday, November 2nd. Evercore ISI raised their price target on shares of Cerner from $73.50 to $75.50 and gave the company a “buy” rating in a research note on Monday, November 2nd. Finally, RBC Capital raised their price target on shares of Cerner from $70.00 to $77.00 and gave the company an “outperform” rating in a research note on Monday, November 2nd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company. Cerner currently has an average rating of “Buy” and a consensus target price of $73.80.

In other Cerner news, EVP Julie M. Wilson sold 2,821 shares of the stock in a transaction that occurred on Monday, December 14th. The shares were sold at an average price of $60.52, for a total transaction of $170,726.92. Following the transaction, the executive vice president now directly owns 32,895 shares in the company, valued at $1,990,805.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Michael R. Battaglioli sold 2,000 shares of the stock in a transaction that occurred on Thursday, December 10th. The shares were sold at an average price of $60.06, for a total transaction of $120,120.00. The disclosure for this sale can be found here.

Cerner Corporation (NASDAQ:CERN) is a supplier of health care information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations. The Company offers software, hardware, professional services and managed services. The Company operates in two segments: Domestic and Global. The Domestic segment includes the business activity in the United States. The Global segment includes the business activity in Aruba, Australia, Austria, Brazil, Canada, Cayman Islands, Chile, Egypt, England, Finland, France, Germany, Guam, India, Ireland, Israel, Malaysia, Mexico, Netherlands, Qatar, Saudi Arabia, Singapore, Spain, Switzerland and the United Arab Emirates. Cerner solutions are offered on the unified Cerner Millennium architecture and on the HealtheIntent cloud-based platform. Its solutions include HealtheRegistries, Cerner ITWorks, Cerner RevWorks, PowerWorks and CommunityWorks, among others.

12 Month Chart for NASDAQ:CERN

Receive News & Ratings for Cerner Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Co. and related companies with MarketBeat.com's FREE daily email newsletter.